Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.

Authors :: Lamothe B
Cervantes-Gomez F
Sivina M
Wierda WG
Keating MJ
Gandhi V
Source :: Blood [Blood] 2015 Jan 08; Vol. 125 (2), pp. 407-10.
Publication Year :: 2015

Subjects :: Adenine analogs & derivatives
Aged
Apoptosis drug effects
Blotting, Western
Female
Humans
In Vitro Techniques
Male
Middle Aged
Oligopeptides administration & dosage
Piperidines
Proteasome Inhibitors administration & dosage
Pyrazoles administration & dosage
Pyrimidines administration & dosage
Tumor Cells, Cultured
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Leukemia, Lymphocytic, Chronic, B-Cell

Full Text Access

Tools